NYSE:HUMHumana Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Humana Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $394.55 +2.10 (+0.54 %) (As of 08/3/2020 04:00 PM ET) Add Compare Share Today's Range$387.90Now: $394.55▼$395.5650-Day Range$374.64MA: $388.29▼$404.4952-Week Range$208.25Now: $394.55▼$412.70Volume446,366 shsAverage Volume1.22 million shsMarket Capitalization$52.16 billionP/E Ratio20.25Dividend Yield0.64%Beta0.86 ProfileAnalyst RatingsAdvanced ChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE South Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2018, the company had approximately 17 million members in medical benefit plans, as well as approximately 6 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Read More Beat the Market (BTM) Rank™ 2.3 Analyst's Opinion Consensus RatingHumana has received a consensus rating of Buy. The company's average rating score is 2.68, and is based on 13 buy ratings, 6 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $415.79, Humana has a potential upside of 5.4% from its current price of $394.55.Amount of Analyst CoverageHumana has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.5 Community Rank Outperform VotesHumana has received 790 “outperform” votes. (Add your “outperform” vote.)Underperform VotesHumana has received 818 “underperform” votes. (Add your “underperform” vote.)Community SentimentHumana has received 50.87% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote “Outperform” if you believe HUM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 2.5 Dividend Strength Dividend YieldHumana has a dividend yield of 0.64%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthHumana has been increasing its dividend for 9 years.Dividend CoverageThe dividend payout ratio of Humana is 13.99%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Humana will have a dividend payout ratio of 11.45% next year. This indicates that Humana will be able to sustain or increase its dividend. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Humana insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.42% of the stock of Humana is held by insiders.Percentage Held by Institutions92.89% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Humana are expected to grow by 16.54% in the coming year, from $18.74 to $21.84 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Humana is 20.25, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 17.37.Price to Earnings Ratio vs. SectorThe P/E ratio of Humana is 20.25, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.41.Price to Earnings Growth RatioHumana has a PEG Ratio of 1.70. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHumana has a P/B Ratio of 4.34. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 2.3Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.92 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Hospital & medical service plans Sub-IndustryManaged Health Care SectorMedical Current SymbolNYSE:HUM Previous Symbol CUSIP44485910 CIK49071 Webwww.humana.com Phone502-580-1000Debt Debt-to-Equity Ratio0.49 Current Ratio1.66 Quick Ratio1.66Price-To-Earnings Trailing P/E Ratio20.25 Forward P/E Ratio21.05 P/E Growth1.7 Sales & Book Value Annual Sales$64.89 billion Price / Sales0.80 Cash Flow$22.64 per share Price / Cash Flow17.43 Book Value$90.90 per share Price / Book4.34Profitability EPS (Most Recent Fiscal Year)$17.87 Net Income$2.71 billion Net Margins3.86% Return on Equity21.02% Return on Assets8.26%Miscellaneous Employees46,000 Outstanding Shares132,206,000Market Cap$52.16 billion Next Earnings Date8/5/2020 (Confirmed) OptionableOptionable $394.55 +2.10 (+0.54 %) (As of 08/3/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive HUM News and Ratings via Email Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter. Humana (NYSE:HUM) Frequently Asked Questions How has Humana's stock been impacted by COVID-19 (Coronavirus)? Humana's stock was trading at $328.22 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HUM shares have increased by 20.2% and is now trading at $394.55. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Humana? 19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 6 hold ratings and 13 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Humana. When is Humana's next earnings date? Humana is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Humana. How can I listen to Humana's earnings call? Humana will be holding an earnings conference call on Wednesday, August 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available. How were Humana's earnings last quarter? Humana Inc (NYSE:HUM) announced its quarterly earnings results on Wednesday, April, 29th. The insurance provider reported $5.40 earnings per share for the quarter, topping the consensus estimate of $4.84 by $0.56. The insurance provider earned $18.94 billion during the quarter, compared to the consensus estimate of $18.49 billion. Humana had a net margin of 3.86% and a return on equity of 21.02%. Humana's revenue was up 17.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.48 EPS. View Humana's earnings history. How often does Humana pay dividends? What is the dividend yield for Humana? Humana announced a quarterly dividend on Thursday, April 23rd. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.625 per share on Friday, July 31st. This represents a $2.50 annualized dividend and a yield of 0.63%. The ex-dividend date of this dividend is Monday, June 29th. View Humana's dividend history. What guidance has Humana issued on next quarter's earnings? Humana updated its FY 2020 Pre-Market earnings guidance on Friday, May, 29th. The company provided earnings per share (EPS) guidance of 18.25-18.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $18.54. What price target have analysts set for HUM? 19 Wall Street analysts have issued twelve-month price targets for Humana's shares. Their forecasts range from $290.00 to $510.00. On average, they expect Humana's stock price to reach $415.79 in the next twelve months. This suggests a possible upside of 5.4% from the stock's current price. View analysts' price targets for Humana. Has Humana been receiving favorable news coverage? News coverage about HUM stock has trended somewhat positive on Tuesday, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Humana earned a news sentiment score of 1.8 on InfoTrie's scale. They also assigned news stories about the insurance provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news about Humana. Are investors shorting Humana? Humana saw a decline in short interest in the month of June. As of June 30th, there was short interest totaling 1,400,000 shares, a decline of 33.3% from the June 15th total of 2,100,000 shares. Based on an average trading volume of 1,210,000 shares, the short-interest ratio is presently 1.2 days. Approximately 1.1% of the company's shares are sold short. View Humana's Current Options Chain. Who are some of Humana's key competitors? Some companies that are related to Humana include UnitedHealth Group (UNH), Anthem (ANTM), Cigna (CI), Centene (CNC), Molina Healthcare (MOH), Magellan Health (MGLN) and Triple-S Management (GTS). View all competitors. What other stocks do shareholders of Humana own? Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Visa (V), Walt Disney (DIS), Alibaba Group (BABA), Mastercard (MA), Boeing (BA), salesforce.com (CRM), JPMorgan Chase & Co. (JPM) and CVS Health (CVS). Who are Humana's key executives? Humana's management team includes the following people: Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 57)Mr. Brian Andrew Kane, Chief Financial Officer (Age 46)Mr. Timothy S. Huval, Chief HR Officer (Age 53)Ms. Jody L. Bilney, Chief Consumer Officer (Age 58)Dr. William Kevin Fleming Pharm.D., PharmD, RPh, Segment Pres of Healthcare Services (Age 51) What is Humana's stock symbol? Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM." Who are Humana's major shareholders? Humana's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.52%), Strs Ohio (0.18%), New York State Teachers Retirement System (0.14%), Robeco Institutional Asset Management B.V. (0.13%), First Trust Advisors LP (0.12%) and Frontier Capital Management Co. LLC (0.12%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James J /Ky Obrien, Roy A Beveridge, Timothy Alan Wheatley and Timothy S Huval. View institutional ownership trends for Humana. Which major investors are selling Humana stock? HUM stock was sold by a variety of institutional investors in the last quarter, including Scout Investments Inc., First Trust Advisors LP, Calamos Advisors LLC, Wedge Capital Management L L P NC, Hexavest Inc., Ardevora Asset Management LLP, Sumitomo Mitsui Trust Holdings Inc., and Retirement Systems of Alabama. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, David A Jr/Ky Jones, Elizabeth D Bierbower, James J /Ky Obrien, Timothy Alan Wheatley, and Timothy S Huval. View insider buying and selling activity for Humana. Which major investors are buying Humana stock? HUM stock was purchased by a variety of institutional investors in the last quarter, including Strs Ohio, MERIAN GLOBAL INVESTORS UK Ltd, Railway Pension Investments Ltd, Frontier Capital Management Co. LLC, Robeco Institutional Asset Management B.V., Stanley Laman Group Ltd., SG Americas Securities LLC, and Pacer Advisors Inc.. View insider buying and selling activity for Humana. How do I buy shares of Humana? Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Humana's stock price today? One share of HUM stock can currently be purchased for approximately $394.55. How big of a company is Humana? Humana has a market capitalization of $52.16 billion and generates $64.89 billion in revenue each year. The insurance provider earns $2.71 billion in net income (profit) each year or $17.87 on an earnings per share basis. Humana employs 46,000 workers across the globe. What is Humana's official website? The official website for Humana is www.humana.com. How can I contact Humana? Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected] This page was last updated on 8/4/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
